Seelos Therapeutics
Manufacturing · New York, United States · 1-10 Employees
View Company Info for Free
Overview
Headquarters
300 Park Ave Fl 2, New York, New York, 1...Phone Number
(646) 293-2100Website
www.seelostherapeutics.comRevenue
$29.8 MillionStock Symbol
SEELIndustry
About Seelos Therapeutics
Seelos Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative therapies for central nervous system (CNS) disorders and rare diseases. Their product pipeline includes treatments such as SLS-002 for acute suicidal ideation in major depressive disorder and PTSD, SLS-004 gene therapy, and SLS-005 intravenous trehalose. The company aims to address significant unmet medical needs and improve patient outcomes. Their intended clients include patients suffering from severe mental health conditions and rare diseases, as well as caregivers and healthcare providers.Explore more
SIC Code 28,283NAICS Code 32,325Ticker NASDAQ: SEELShow moreSeelos Therapeutics Org Chart
Compare Similar Companies to Seelos Therapeutics
Compare insights from companies similar to Seelos Therapeutics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Seelos Therapeutics Tech Stack
A closer look at the technologies used by Seelos Therapeutics
See more technologies
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Seelos Therapeutics
Sign Up For FreeTo access detailed company insights
Seelos Therapeutics, Inc. is a clinical-stage biotechnology company focused on developing innovative therapies for central nervous system (CNS) disorders and rare diseases. Their product pipeline includes treatments such as SLS-002 for acute suicidal ideation in major depressive disorder and PTSD, SLS-004 gene therapy, and SLS-005 intravenous treha... Read More